Obesity is a growing health concern worldwide, with at least 2.8 million people dying each year as a result of the disease. Additionally, the number of individuals living with obesity continues to increase annually across age, gender and geographic location. A complex condition, obesity has implications in inflammatory, metabolic and cardiovascular health — which, together, mean that advancing the treatment of obesity also means accounting for its relationships with other physiological systems and health conditions.

Read the whitepaper to learn:

• The foundational physiology and drivers of obesity
• How obesity impacts inflammatory, metabolic and cardiovascular health
• Current approaches to treating obesity
• Considerations for future obesity drug development, including long-term health solutions and multidisciplinary and combination therapies
• Unique challenges and approaches in participant recruitment and retention for obesity-related clinical trials
• Considerations for clinical trial design focused on obesity treatments
• Why and how to plan for long-term follow-up for obesity treatments.